Effect of Social Media Support and Financial Incentives on PrEP Adherence
Status: | Recruiting |
---|---|
Healthy: | No |
Age Range: | 18 - 24 |
Updated: | 4/17/2018 |
Start Date: | April 1, 2017 |
End Date: | November 2019 |
Contact: | Chelsea Ware, MS |
Email: | cware@mfa.gwu.edu |
Phone: | 202-677-6496 |
The Effect of Social Media Support and Financial Incentives on Adherence to HIV Pre-exposure Prophylaxis in Young MSM of Color in Washington, DC
The purpose of this study is to determine if social media support and financial incentives
improve adherence to Truvada as PrEP in African American, Latino and Asian MSM aged 18 to 24
living in the Washington, DC area who are at high risk for HIV acquisition.
improve adherence to Truvada as PrEP in African American, Latino and Asian MSM aged 18 to 24
living in the Washington, DC area who are at high risk for HIV acquisition.
Inclusion Criteria:
- Male assigned at birth (regardless of current gender identity)
- Age 18-24
- Black/African American, Latino or Asian
- HIV negative
- History of unprotected anal sex with a man in the last 6 months
- Living within the DC metropolitan statistical area and anticipate remaining within the
DC area for the next 6 months
- Not enrolled in any other HIV prevention trial
- Interested in taking PrEP
- Not a current PrEP user and have not taken PrEP in the last 30 days
- Able to provide informed consent
Exclusion Criteria:
- Female sex at birth
- Age younger than 18 or older than 24
- Caucasian
- HIV positive
- Actively taking PrEP or having taken PrEP within 30 days of enrollment
- Chronic hepatitis B infection
- Known renal insufficiency
- On probation or parole
- Any other conditions that the Principal Investigator may consider a contraindication
to enrolling in the study
We found this trial at
2
sites
110 Irving Street Northwest
Washington, District of Columbia 20010
Washington, District of Columbia 20010
Principal Investigator: Ruth Kanthula, MD
Phone: 202-677-6496
Click here to add this to my saved trials
Washington, District of Columbia 20037
Principal Investigator: Marc Siegel, MD
Phone: 202-677-6496
Click here to add this to my saved trials